Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Swaddling and Breast Milk Odor for Stress and Comfort in Late Preterm Babies Receiving High-Flow Breathing Support Through the Nose

10 november 2026 bijgewerkt door: Hediye Karakoç, KTO Karatay University

The Effect of the Safe Swaddling Method and the Scent of Breast Milk on Physiological Parameters, Stress, and Comfort Levels in Premature Newborns Receiving Mechanical Ventilator Support: A Randomized Controlled Study

This study compared two approaches to reducing stress and improving comfort in babies born between 34 and 36 completed weeks of pregnancy who were receiving high-flow breathing support through small tubes in the nose.

Seventy-two babies were assigned by chance to one of three groups, with 24 babies in each group. One group was gently swaddled for 20 minutes. A second group was exposed for 20 minutes to the smell of freshly expressed milk from each baby's own mother. The third group received the neonatal intensive care unit's usual care and was observed for 20 minutes.

The study team assessed stress and comfort and recorded heart rate, breathing rate, blood oxygen level, and body temperature at the start of the observation period and again at 5 and 20 minutes. The purpose was to compare how these measures changed over time across the three groups.

Studie Overzicht

Toestand

Voltooid

Conditie

Studietype

Ingrijpend

Inschrijving (Werkelijk)

72

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Karatay
      • Konya, Karatay, Turkije (Türkiye), 42040
        • KTO Karatay University

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

7 maanden tot 8 maanden (Kind)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Gestational age at birth of 34 weeks 0 days to 36 weeks 6 days, inclusive.
  • Within the first 28 days of life at enrollment.
  • Receiving noninvasive respiratory support via a high-flow nasal cannula (HFNC).
  • Birth weight of at least 1,500 g.
  • The infant's mother was able to provide expressed breast milk.
  • No clinical condition that precluded safe positioning or swaddling.
  • Written informed consent obtained from a parent.

Exclusion Criteria:

  • A painful procedure within 1 hour before the start of the planned study session.
  • Receipt of a medication with analgesic or sedative effects within 6 hours before the start of the planned study session.
  • Previous surgery.
  • An active or treatment-requiring clinical condition that could affect physiological measurements or the stress response, such as hypoglycemia, hyperbilirubinemia, or acute infection.
  • Cerebral hypoxia or ischemia.
  • Intraventricular hemorrhage.
  • A major congenital anomaly.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Maternal Breast Milk Odor

Infants were exposed for 20 minutes to the odor of freshly expressed breast milk from their own mothers. Ten drops of milk were applied to sterile gauze placed in a sterile container. The container was positioned inside the incubator approximately 1-2 cm from the infant's nose and remained in place throughout the exposure period.

Ten drops of freshly expressed breast milk from each infant's own mother were applied to sterile gauze in a sterile container. The container was placed inside the incubator near the infant's nose for 20 minutes.

Experimenteel: Safe Swaddling

Infants were positioned supine and swaddled for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The upper limbs were held alongside the trunk in slight flexion. The lower limbs were left free to allow hip flexion and abduction. The cloth was secured loosely enough to permit chest expansion and spontaneous movement.

Infants were swaddled in the supine position for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The cloth was secured loosely to allow chest expansion and spontaneous movement, and the lower limbs were left free to permit hip flexion and abduction.

Geen tussenkomst: Standard Care

Infants received the neonatal intensive care unit's standard care during a 20-minute observation period. No additional study intervention was administered.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in Newborn Stress Scale Total Score Over Time
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Stress was assessed using the Newborn Stress Scale. The scale comprises eight observational domains, each scored from 0 to 2. Total scores range from 0 to 16, with higher scores indicating greater stress. Changes in total scores across the three assessment time points were compared among the study groups.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Premature Infant Comfort Scale Total Score
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Comfort was assessed using the Turkish version of the Premature Infant Comfort Scale. Seven indicators are each scored from 1 to 5. Total scores range from 7 to 35, with lower scores indicating greater comfort.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Heart Rate
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Heart rate was read directly from the bedside monitor and recorded in beats per minute.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Respiratory Rate
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Respiratory rate was read directly from the bedside monitor and recorded in breaths per minute.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Peripheral Oxygen Saturation (SpO₂)
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Peripheral oxygen saturation was read directly from the bedside monitor and recorded as a percentage.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Body Temperature
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Body temperature was read directly from the bedside monitor and recorded in degrees Celsius (°C).

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Hediye Karakoç, KTO Karatay Üniversitesi

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

28 juni 2024

Primaire voltooiing (Werkelijk)

30 april 2026

Studie voltooiing (Werkelijk)

30 augustus 2026

Studieregistratiedata

Eerst ingediend

19 augustus 2025

Eerst ingediend dat voldeed aan de QC-criteria

1 juli 2026

Eerst geplaatst (Werkelijk)

2 juli 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

13 november 2026

Laatste update ingediend die voldeed aan QC-criteria

10 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Beschrijving IPD-plan

Security

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren